Folgen
Boris Turk
Boris Turk
Professor of Biochemistry, Head of Department of Biochemistry and Molecular and Structural Biology
Bestätigte E-Mail-Adresse bei ijs.si
Titel
Zitiert von
Zitiert von
Jahr
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, DJ (Klionsky, FC Abdalla, FC (Abdalla, ...
Autophagy 8 (4), 445-544, 2012
14105*2012
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ...
Cell Death & Differentiation 25 (3), 486-541, 2018
63262018
Targeting proteases: successes, failures and future prospects
B Turk
Nature reviews Drug discovery 5 (9), 785-799, 2006
17522006
Cysteine cathepsins: from structure, function and regulation to new frontiers
V Turk, V Stoka, O Vasiljeva, M Renko, T Sun, B Turk, D Turk
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1824 (1), 68-88, 2012
15962012
Lysosomal cysteine proteases: more than scavengers
B Turk, D Turk, V Turk
Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular …, 2000
11642000
Lysosomal cysteine proteases: facts and opportunities
V Turk, B Turk, D Turk
The EMBO journal, 2001
10432001
Lysosomal protease pathways to apoptosis: cleavage of Bid, not pro-caspases, is the most likely route
V Stoka, B Turk, SL Schendel, TH Kim, T Cirman, SJ Snipas, LM Ellerby, ...
Journal of Biological Chemistry 276 (5), 3149-3157, 2001
8812001
Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.
B Turk, V Turk, D Turk
Biological chemistry 378 (3-4), 141-150, 1997
6431997
Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins
T Cirman, K Orešić, GD Mazovec, V Turk, JC Reed, RM Myers, ...
Journal of Biological Chemistry 279 (5), 3578-3587, 2004
6112004
Emerging roles of cysteine cathepsins in disease and their potential as drug targets
O Vasiljeva, T Reinheckel, C Peters, D Turk, V Turk, B Turk
Current pharmaceutical design 13 (4), 387-403, 2007
5852007
Lysosomes and lysosomal cathepsins in cell death
U Repnik, V Stoka, V Turk, B Turk
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1824 (1), 22-33, 2012
4682012
Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues
G Droga-Mazovec, L Bojic, A Petelin, S Ivanova, U Repnik, GS Salvesen, ...
Journal of Biological Chemistry 283 (27), 19140-19150, 2008
4622008
Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment
G Mikhaylov, U Mikac, AA Magaeva, VI Itin, EP Naiden, I Psakhye, ...
Nature nanotechnology 6 (9), 594-602, 2011
4412011
Cysteine cathepsins and extracellular matrix degradation
M Fonović, B Turk
Biochimica et Biophysica Acta (BBA)-general subjects 1840 (8), 2560-2570, 2014
4012014
Lysosomal cathepsins and their regulation in aging and neurodegeneration
V Stoka, V Turk, B Turk
Ageing research reviews 32, 22-37, 2016
3802016
Cysteine cathepsins and their extracellular roles: shaping the microenvironment
E Vidak, U Javoršek, M Vizovišek, B Turk
Cells 8 (3), 264, 2019
3712019
Protease signalling: the cutting edge
B Turk, D Turk, V Turk
The EMBO journal 31 (7), 1630-1643, 2012
3532012
Lysosomes as “suicide bags” in cell death: myth or reality?
B Turk, V Turk
Journal of Biological Chemistry 284 (33), 21783-21787, 2009
3352009
Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators
B Turk, D Turk, GS Salvesen
Current pharmaceutical design 8 (18), 1623-1637, 2002
3292002
Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases
D Turk, V Janjić, I Štern, M Podobnik, D Lamba, SW Dahl, C Lauritzen, ...
The EMBO journal, 2001
3252001
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20